School of Industrial and Management Engineering, Hankuk University of Foreign Studies, 89 Wangsan-ri, Mohyeon-myeon, Yongin-si, Gyeonggi-do, 449-491, South Korea.
Comput Methods Programs Biomed. 2012 Feb;105(2):95-108. doi: 10.1016/j.cmpb.2011.07.009. Epub 2011 Aug 9.
To evaluate the cardiac hypertrophy from chest radiograph images, radiologists usually examine the cardiothoracic ratio (frequently called CTR) which is a standard diagnostic index. The CTR is computed by the maximum transverse diameter of the heart shadow divided by the maximum transverse diameter of right and left lung boundaries. In this paper, we present a method to evaluate the cardiac hypertrophy by comparing the area of heart with that of lung, instead of the cardiothoracic ratio to get more desirable diagnostic results. We introduce a new index, a cardiothoracic area ratio (CTAR), which is computed by dividing the area of heart region by the area of lung region of specific interest. We first segment a chest region of interest in a radiograph image and then automatically compute the traditional CTR and the CTAR to evaluate the cardiac hypertrophy. And finally, we provide the visual presentation of those ratios on the chest radiograph image. The experimental results using a set of radiograph images show that the proposed method can be used effectively for determining the cardiac hypertrophy in a real-time diagnostic environment. It provides the higher discrimination power than the CTR to identify hypertrophied hearts by recognizing the heart enlargement. It also can be used together with the traditional CTR as a complementary measure when it is difficult to determine abnormalities by the CTR, reducing the rate of wrong diagnosis.
为了从胸部 X 光图像评估心脏肥大,放射科医生通常会检查心胸比(通常称为 CTR),这是一个标准的诊断指标。CTR 通过心脏阴影的最大横径除以左右肺边界的最大横径计算得出。在本文中,我们提出了一种通过比较心脏区域与肺部区域的面积来评估心脏肥大的方法,而不是使用心胸比,以获得更理想的诊断结果。我们引入了一个新的指数,即心胸面积比(CTAR),它通过将心脏区域的面积除以特定感兴趣区域的肺部区域的面积来计算。我们首先在 X 光图像中分割感兴趣的胸部区域,然后自动计算传统的 CTR 和 CTAR 来评估心脏肥大。最后,我们在胸部 X 光图像上提供这些比值的直观表示。使用一组 X 光图像的实验结果表明,该方法可有效用于在实时诊断环境中确定心脏肥大。它通过识别心脏增大,提供比 CTR 更高的区分能力来识别肥大的心脏。当难以通过 CTR 确定异常时,它还可以与传统的 CTR 一起作为补充措施使用,降低误诊率。